Seizures and type 1 diabetes mellitus: Current state of knowledge

European Journal of Endocrinology

Volumn 167, Issue 6, 2012, Pages 749-758

  Verrotti, Alberto ^a   Scaparrotta, Alessandra ^a   Olivieri, Cristina ^a   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN;

ANTIBODY TITER; AUTOIMMUNITY; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; EEG ABNORMALITY; EPILEPSY; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEIZURE;

ADOLESCENT; ADULT; ANIMALS; AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; EPILEPSY; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; SEIZURES; YOUNG ADULT;

EID: 84869053372     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0699     Document Type: Review

References (87)

1. Tsirogianni A, Pipi E & Soufleros K. Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus. Autoimmunity Reviews 2009 8 687-691. (doi:10.1016/j.autrev. 2009.02.019)
2. Vincent A & Crino PB. Systemic and neurologic autoimmune disorders associated with seizures or epilepsy. Epilepsia 2011 52 12-17. (doi:10.1111/j.1528-1167.2011.03030.x)
3. Soltész G & Acsádi G. Association between diabetes, severe hypoglycaemia, and electroencephalographic abnormalities. Archives of Disease in Childhood 1989 64 992-996. (doi:10.1136/adc.64. 7.992)
4. Ottman R, Lipton RB, Ettinger AB, Cramer JA, Reed ML, Morrison A & Wan GJ. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011 52 308-315. (doi:10.1111/j.1528-1167.2010. 02927.x)
5. Irani SR, Bien CG & Lang B. Autoimmune epilepsies. Current Opinion in Neurology 2011 24 146-153. (doi:10.1097/WCO. 0b013e3283446f05)
6. Bien CG & Scheffer IE. Autoantibodies and epilepsy. Epilepsia 2011 52 18-22. (doi:10.1111/j.1528-1167.2011.03031.x)
7. McCorry D, Nicolson A, Smith D, Marson A, Feltbower RG & Chadwick DW. An association between type 1 diabetes and idiopathic generalized epilepsy. Annals of Neurology 2006 59 204-206. (doi:10.1002/ana.20727)
8. O'Connell MA, Harvey AS, Mackay MT & Cameron FJ. Does epilepsy occur more frequently in children with Type 1 diabetes? Journal of Paediatrics and Child Health 2008 44 586-589. (doi:10.1111/j.1440-1754.2008.01387.x)
9. Cotellessa M, Barbieri P, Mazzella M, Bonassi S, Minicucci L & Lorini R. High incidence of childhood type 1 diabetes in Liguria, Italy, from 1989 to 1998. Diabetes Care 2003 26 1786-1789. (doi:10.2337/diacare.26.6.1786)
10. Mancardi MM, Striano P, Giannattasio A, Baglietto MG, Errichiello L, Zara F, Prato G, Minuto N, Veneselli E, Lorini R & D'Annunzio G. Type 1 diabetes and epilepsy: more than a casual association? Epilepsia 2010 51 320-321. (doi:10.1111/j.1528- 1167.2009.02380.x)
11. Eeg-Olofsson O & Petersen I. Childhood diabetic neuropathy. A clinical and neurophysiological study. Acta Paediatrica Scandinavica 1969 55 163-176. (doi:10.1111/j.1651-2227.1966.tb15222.x)
12. Eeg-Olofsson O. Hypoglycemia and neurological disturbances in children with diabetes mellitus. Acta Paediatrica Scandinavica 1977 270 91-96. (doi:10.1111/j.1651-2227.1977.tb15127.x)
13. Huang CW, Hsieh YJ, Huang CC & Tsai JJ. Non-ketotic hyperglycaemia-related paroxysmal bilateral hand paraesthesia misdiagnosed as diabetic neuropathy. Neurological Sciences 2006 27 180-182. (doi:10.1007/s10072- 006-0665-0)
14. Maccario M, Messis CP & Vastola F. Focal seizures as a manifestation of hyperglycaemia without ketoacidosis. Neurology 1965 15 195-206. (doi:10.1212/WNL.15.3.195)
15. Loeb JH. The hyperosmolar state. New England Journal of Medicine 1974 290 1184-1187. (doi:10.1056/NEJM19740523290 2107)
16. DeCaro LJ, Reinig M & Croft BT. Clonic focal seizure of the foot secondary to nonketotic hyperglycemia. Journal of the American Podiatric Medical Association 2002 92 109-111.
17. Hennis A, Corbin D & Fraser H. Focal seizures and non-ketotic hyperglycaemia. Journal of Neurology, Neurosurgery, and Psychiatry 1992 55 195-197. (doi:10.1136/jnnp.55.3.195)
18. Grant C & Warlow C. Focal epilepsy in diabetic non-ketotic hyperglycaemia. BMJ 1985 290 1204-1205. (doi:10.1136/bmj. 290.6476.1204)
19. Whiting S, Camfield P, Arab D & Salisbury S. Insulin-dependent diabetes mellitus presenting in children as frequent, medically unresponsive, partial seizures. Journal of Child Neurology 1997 12 178-180. (doi:10.1177/088307389701200305)
20. Mukherjee V, Mukherjee A, Mukherjee A & Halder A. Type 1 diabetes mellitus in a child presenting with epilepsy partialis continua. Journal of the Indian Medical Association 2007 105 340-342.
21. Cokar O, Aydin B & Ozer F. Non-ketotic hyperglycaemia presenting as epilepsia partialis continua. Seizure 2004 13 264-269. (doi:10.1016/S1059- 1311(03)00155-9)
22. Guerreiro CA, Falcão AE & Silveira DC. Focal seizures in nonketotic hyperglycemia. Arquivos de Neuro-Psiquiatria 1991 49 447-449. (doi:10.1590/S0004-282X1991000400014)
23. Singh BM & Strobos RJ. Epilepsia partialis continua associated with nonketotic hyperglycemia: clinical and biochemical profile of 21 patients. Annals of Neurology 1980 8 155-160. (doi:10.1002/ ana.410080205)
24. Sabitha KM, Girija AS & Vargese KS. Seizures in hyperglycemic patients. Journal of the Association of Physicians of India 2001 49 723-726.
25. Kumar S. Epilepsia partialis continua stopped by insulin. Journal of the Royal Society of Medicine 2004 97 332-333. (doi:10.1258/ jrsm.97.7.332)
26. Sabharwal RK, Gupta M, Sharma D & Puri V. Juvenile diabetes manifesting as epilepsia partialis continua. Journal of the Association of Physicians of India 1989 37 603-604.
27. Baglietto MG, Mancardi MM, Giannattasio A, Minuto N, Rossi A, Capovilla G, Veneselli E, Lorini R & D'Annunzio G. Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep. Neurological Sciences 2009 30 509-512. (doi:10.1007/s10072- 009-0122-y)
28. Olson JA, Olson DM, Sandborg C, Alexander S & Buckingham B. Type 1 diabetes mellitus and epilepsia partialis continua in a 6-year-old boy with elevated anti-GAD65 antibodies. Pediatrics 2002 109 E50. (doi:10.1542/peds.109. 3.e50)
29. Hung WL, Hsieh PF, Lee YC & Chang MH. Occipital lobe seizures related to marked elevation of hemoglobin A1C: report of two cases. Seizure 2010 19 359-362. (doi:10.1016/j.seizure.2010. 05.006)
30. Raghavendra S, Ashalatha R, Thomas SV & Kesavadas C. Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with a nonketotic hyperglycemic hyperosmolar state. Neuroradiology 2007 49 299-305. (doi:10.1007/s00234-006- 0189-6)
31. Wang CP, Hsieh PF, Chen CC, Lin WY, Hu WH, Yang DY & Chang MH. Hyperglycemia with occipital seizures: images and visual evoked potentials. Epilepsia 2005 46 1140-1144. (doi:10.1111/j.1528-1167.2005.56404.x)
32. Martínez MD & Megías SM. Occipital seizures with electroencephalographic alterations as the initial manifestation of diabetes mellitus. Endocrinología y Nutrició n 2009 56 458-460. (doi:10.1016/S1575-0922(09)73314-5)
33. Moien-Afshari F & Téllez-Zenteno JF. Occipital seizures induced by hyperglicemia: a case report and review of literature. Seizure 2009 18 382-385. (doi:10.1016/j.seizure.2008.12.001)
34. Tiras R, Mutlu A, Ozben S, Aydemir T & Ozer F. Forced eye closureinduced reflex seizure and non-ketotic hyperglycemia. Annals of Saudi Medicine 2009 29 313-315. (doi:10.4103/0256-4947. 55319)
35. Siddiqi ZA, VanLandingham KE & Husain AM. Reflex seizures and non-ketotic hyperglycemia: an unresolved issue. Seizure 2002 11 63-66. (doi:10.1053/seiz.2001.0559)
36. Ozer F, Mutlu A & Ozkayran T. Reflex epilepsy and non-ketotic hyperglycemia. Epileptic Disorders: International Epilepsy Journal with Videotape 2003 5 165-168.
37. Peltola J, Kulmala P, Isojärvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Keränen T & Graus F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000 55 46-50. (doi:10.1212/WNL.55.1.46)
38. Striano P, Perruolo G, Errichiello L, Formisano P, Beguinot F, Zara F & Striano S. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Annals of Neurology 2008 63 127-128. (doi:10.1002/ana.21011)
39. Schober E, Otto KP, Dost A, Jorch N & Holl R. German/Austrian DPV, initiative and the BMBF competence network diabetes, association of epilepsy and type 1 diabetes mellitus in children and adolescents: is there an increased risk for diabetic ketoacidosis? Journal of Pediatrics 2012 160 662-666. (doi:10.1016/j.jpeds. 2011.09.054)
40. Wayne EA, Dean HJ, Booth F & Tenenbein M. Focal neurological deficits associated with hypoglycemia in children with diabetes. Journal of Pediatrics 1990 117 575-577. (doi:10.1016/S0022- 3476(05)80691-2)
41. Lahat E, Barr J & Bistritzer T. Focal epileptic episodes associated with hypoglycemia in children with diabetes. Clinical Neurology and Neurosurgery 1995 97 314-316. (doi:10.1016/0303-8467(95) 00072-R)
42. Ranua J, Luoma K, Auvinen A, Haapala AM, Mäki M, Peltola J, Raitanen J & Isojärvi JI. Antimitochondrial antibodies in patients with epilepsy. Epilepsy & Behavior 2005 7 95-97. (doi:10.1016/j. yebeh.2005.04.001)
43. Striano P, Errichiello L & Striano S. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy: what is their clinical relevance? Epilepsy & Behavior 2011 20 145.
44. Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L & Graus F. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008 131 2553-2563. (doi:10.1093/brain/awn183)
45. Stagg CJ, Lang B, Best JG, McKnight K, Cavey A, Johansen-Berg H, Vincent A & Palace J. Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010 51 1898-1901. (doi:10.1111/j. 1528-1167.2010.02644.x)
46. Errichiello L, Striano S, Zara F & Striano P. Temporal lobe epilepsy and anti glutamic acid decarboxylase autoimmunity. Neurological Sciences 2011 32 547-550. (doi:10.1007/s10072-011-0566-8)
47. Vianello M, Bisson G, Dal Maschio M, Vassanelli S, Girardi S, Mucignat C, Fountzoulas K & Giometto B. Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies. Autoimmunity 2008 41 66-73. (doi:10.1080/ 08916930701619565)
48. Kwan P, Sills GJ, Kelly K, Butler E & Brodie MJ. Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. Epilepsy Research 2000 42 191-195. (doi:10.1016/S0920-1211(00)00180-7)
49. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J & Lang B. Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005 65 1730-1736. (doi:10.1212/01.wnl. 0000187129.66353.13)
50. Verrotti A, Greco R, Altobelli E, Latini G, Morgese G & Chiarelli F. Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients. Clinical and Experimental Medicine 2003 3 32-36. (doi:10.1007/s102380300013)
51. Yoshimoto T, Doi M, Fukai N, Izumiyama H, Wago T, Minami I, Uchimura I & Hirata Y. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Internal Medicine 2005 44 1174-1177. (doi:10.2169/ internalmedicine.44.1174)
52. Errichiello L, Perruolo G, Pascarella A, Formisano P, Minetti C, Striano S, Zara F & Striano P. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. Journal of Neuroimmunology 2009 211 120-123. (doi:10.1016/j.jneuroim.2009.04.010)
53. Liimatainen S, Peltola M, Sabater L, Fallah M, Kharazmi E, Haapala AM, Dastidar P, Knip M, Saiz A & Peltola J. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia 2010 51 760-767. (doi:10.1111/j.1528- 1167.2009.02325.x)
54. Vianello M, Tavolato B & Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurological Sciences 2002 23 145-151. (doi:10.1007/s100720200055)
55. Fishman PS & Drachman DB. Internalization of IgG in motoneurons of patients with ALS: selective or nonselective? Neurology 1995 45 1551-1554. (doi:10.1212/WNL.45.8.1551)
56. Jin H, Wu H, Osterhaus G, Wei J, Davis K, Sha D, Floor E, Hsu CC, Kopke RD &Wu JY. Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles. PNAS 2003 100 4293-4298. (doi:10.1073/pnas.0730698100)
57. Rüegg S. Anti-glutamic acid decarboxylase anti-bodies: the missing link between epilepsy and diabetes. Annals of Neurology 2006 59 728-729.
58. Vulliemoz S & Seeck M. An association between type 1 diabetes and idiopathic generalized epilepsy. Annals of Neurology 2006 59 728. (doi:10.1002/ana.20830)
59. Kim J, Namchuk M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck CW, Erlich H, Lennon V & Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. Journal of Experimental Medicine 1994 180 595-606. (doi:10.1084/jem. 180.2.595)
60. Honorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P & Graus F. Cerebellar ataxia with antiglutamic acid decarboxylase antibodies. Archives of Neurology 2001 58 225-230. (doi:10.1001/archneur.58.2.225)
61. Espay AJ & Chen R. Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle & Nerve 2006 34 677-690. (doi:10.1002/mus.20653)
62. Levy LM, Levy-Reis I, Fujii M & Dalakas MC. Brain gammaaminobutyric acid changes in stiff-person syndrome. Archives of Neurology 2005 62 970-974. (doi:10.1001/archneur.62.6.970)
63. Kanter IC, Huttner HB, Staykov D, Biermann T, Struffert T, Kerling F, Hilz MJ, Schellinger PD, Schwab S & Bardutzky J. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 2008 49 914-920. (doi:10.1111/j. 1528-1167.2007.01500.x)
64. Nishimura T, Kubosaki A, Ito Y & Notkins AL. Disturbances in the secretion of neurotransmitters in IA-2/IA-2b null mice: changes in behavior, learning and life span. Neuroscience 2009 159 427-437. (doi:10.1016/j. neuroscience.2009.01.022)
65. Lapenta L, Di Bonaventura C, Fattouch J, Bonini F, Petrucci S, Gagliardi S, Casciato S, Manfredi M, Prencipe M & Giallonardo AT. Focal epileptic seizure induced by transient hypoglycaemia in insulin-treated diabetes. Epileptic Disorders: International Epilepsy Journal with Videotape 2010 12 84-87.
66. Windebank AJ & McEvoy KM. Diabetes and the nervous system. In Neurology and General Medicine: The Neurological Aspect of Medical Disorders, edn 2, pp 349-381. Ed. MJ Aminoff, New York: Churchill Livingstone, 1995.
67. Manford M, Fuller GN & Wade JP. "Silent diabetes": non-ketotic hyperglycaemia presenting as aphasic status epilepticus. Journal of Neurology, Neurosurgery, and Psychiatry 1995 59 99-100. (doi:10.1136/jnnp.59.1. 99-a)
68. Goto H, Kumagai T & Momozaki N. MRI findings of occipital seizures in non-ketotic hyperglycemia. Internal Medicine 2011 50 367-368. (doi:10.2169/internalmedicine.50.4684)
69. Lee HS & Hwang JS. Cerebral infarction associated with transient visual loss in child with diabetic ketoacidosis. Diabetic Medicine 2011 28 516-518. (doi:10.1111/j.1464-5491.2011.03241.x)
70. Varghese P, Gleason V, Sorokin R, Senholzi C, Jabbour S & Gottlieb JE. Hypoglycemia in hospitalized patients treated with antihyperglycemic agents. Journal of Hospital Medicine 2007 4 234-240. (doi:10.1002/jhm.212)
71. McCall AL. Cerebral glucose metabolism in diabetes mellitus. European Journal of Pharmacology 2004 490 147-158. (doi:10. 1016/j.ejphar.2004.02.052)
72. Auer RN. Hypoglycemic brain damage. Metabolic Brain Disease 2004 19 169-175. (doi:10.1023/B:MEBR.0000043967.78763.5b)
73. Caraballo RH, Sakr D, Mozzi M, Guerrero A, Adi JN, Cersósimo RO & Fejerman N. Symptomatic occipital lobe epilepsy following neonatal hypoglycaemia. Pediatric Neurology 2004 31 24-29. (doi:10.1016/j.pediatrneurol. 2003.12.008)
74. Hyllienmark L, Maltez J, Dandenell A, Ludvigsson J & Brismar T. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes. Diabetologia 2005 48 412-419. (doi:10.1007/s00125-004- 1666-2)
75. Hauser E, Strohmayer C, Seidl R, Birnbacher R, Lischka A & Schober EJ. Quantitative EEG in young diabetics. Journal of Child Neurology 1995 10 330-334. (doi:10.1177/08830 7389501000419)
76. Bjorgaas M, Sand T & Gimse R. Quantitative EEG in type 1 diabetic children with and without episodes of severe hypoglycemia: a controlled, blind study. Acta Neurologica Scandinavica 1996 93 398-402. (doi:10.1111/j.1600-0404. 1996.tb00017.x)
77. Howorka K, Pumprla J, Saletu B, Anderer P, Krieger M & Schabmann A. Decrease of vigilance assessed by EEG-mapping in type I diabetic patients with history of recurrent severe hypoglycaemia. Psychoneuroendocrinology 2000 25 85-105. (doi:10.1016/S0306-4530(99)00041-4)
78. Tsalikian E, Becker DJ, Crumrine PK, Daneman D & Drash AL. Electroencephalographic changes in diabetic ketosis in children with newly and previously diagnosed insulin-dependent diabetes mellitus. Journal of Pediatrics 1981 99 355-359. (doi:10.1016/ S0022-3476(81)80317-4)
79. Haumont D, Dorchy H & Pelc S. EEG abnormalities in diabetic children: influence of hypoglycemia and vascular complications. Clinical Pediatrics 1979 18 750-753. (doi:10.1177/ 000992287901801205)
80. Dorchy H. To: Hyllienmark L, Maltez J, Dandenell A, Ludvigsson J & Brismar T. EEG abnormalities with and without relation to severe hypoglycaemia in adolescents with type 1 diabetes. Diabetologia 2005 48 2191-2192 (Comment on Diabetologia 2005 48 412-419).
81. Keene DL, Metrakos K, Belmonte M, Watters GV & Singer S. EEG abnormalities and convulsions in juvenile diabetes mellitus. Canadian Journal of Neurological Sciences 1983 10 198-199.
82. Halonen H, Hiekkala H, Huupponen T & Häkkinen VK. A followup EEG study in diabetic children. Annals of Clinical Research 1983 15 167-172.
83. Bjørgaas M, Sand T, Vik T & Jorde R. Quantitative EEG, during controlled hypoglycaemia in diabetic and non-diabetic children. Diabetic Medicine 1998 15 30-37. (doi:10.1002/(SICI)1096- 9136(199801)15:1<30::AID- DIA526>3.0.CO;2-R)
84. Tupola S, Saar P & Rajantie J. Abnormal electroencephalogram at diagnosis of insulin-dependent diabetes mellitus may predict severe symptoms of hypoglycemia in children. Journal of Pediatrics 1998 133 792-794. (doi:10.1016/S0022-3476(98)70154-4)
85. Brismar T, Hyllienmark L, Ekberg K & Johansson BL. Loss of temporal lobe beta power in young adults with type 1 diabetes mellitus. Neuroreport 2002 13 2469-2473. (doi:10.1097/ 00001756-200212200-00019)
86. Åsvold BO, Sand T, Hestad KA & Bjørgaas MR. Quantitative EEG in type 1 diabetic adults with childhood exposure to severe hypoglycaemia: a 16 year follow-up study. Diabetologia 2011 54 2404-2408. (doi:10.1007/s00125- 011-2208-3)
87. Northam EA & Lin A. Hypoglycaemia in childhood onset type 1 diabetes-part villain, but not the only one. Pediatric Diabetes 2010 11 134-141. (doi:10.1111/j.1399-5448.2009.00545.x)